Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA names Horizon CEO board member

This article was originally published in Scrip

Executive Summary

Timothy P Walbert, chair, president and CEO of Horizon Pharma, has been named a member of the board of directors for the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA represents the country's leading biopharmaceutical research and biotechnology companies, and is devoted to advancing public policies in the US and around the world that support innovative medical research. Mr Walbert joined Horizon Pharma in 2008 as president and CEO, and has served as chair of the company's board of directors since 2010. Prior to joining Horizon, Mr Walbert was president, CEO and director of IDM Pharma, a public biopharmaceutical company acquired by Takeda in June 2009.

Advertisement
Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC028575

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel